Acutus Medical

AFIB · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0001

Key indicators

AFIB profitability and balance sheet ratios

EPS -$0.0472 in Dec 2024, against -$0.417 a year earlier.

EPS by quarter
PeriodEPS
Q1 FY23-$0.5675
Q2 FY23-$0.6319
Q3 FY23-$0.4523
Q4 FY23-$0.417
Q1 FY24-$0.0546
Jun 2024-$0.0308
Sep 2024-$0.1882
Dec 2024-$0.0472

Where the money went

Q1 FY24, from revenue to net income

Acutus Medical brought in $3.6M of revenue in Q1 FY24, +191.9% on a year earlier. It made a net loss of $1.6M.

Revenue
$3.6M
Costs, expenses and taxes
$5.2M
Net income
−$1.6M
Net margin
-44.7%

Income statement

Revenue and profit by reporting period

Revenue
Net income
AFIB income statement, quarterly
Line itemQ3 FY23Q4 FY23Q1 FY24
Revenue$2.1M$2.3M$3.6M
Gross profit−$1.1M−$0.1M−$0.0M
Operating income−$4.3M−$5.5M−$3.4M
Net income−$13.2M−$33.8M−$1.6M
Diluted EPS-$0.45-$1.15-$0.06

Balance sheet

What the company owns and owes at period end

Total assets
Total liabilities
AFIB balance sheet, quarterly
Line itemJun 2024Sep 2024Dec 2024
Total assets$35.5M$32.2M$28.6M
Total liabilities$40.3M$42.5M$40.2M
Shareholder equity−$4.8M−$10.3M−$11.6M
Cash and short-term investments$13.3M$12.6M$14.0M
Total debt$32.2M$32.4M$32.6M

Cash flow

Cash in and out from operations, investing and financing

Operating
Investing
Financing
AFIB cash flow, quarterly
Line itemQ3 FY23Q4 FY23Q1 FY24
Operating cash flow−$14.0M−$18.0M−$16.9M
Investing cash flow$16.9M$11.2M$9.2M
Financing cash flow−$1.9M−$0.5M−$0.0M
Capital expenditure−$0.4M−$1.0M−$0.1M
Free cash flow−$14.4M−$19.0M−$17.0M

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.